Selegiline (oral)

Revision as of 12:23, 25 September 2011 by Perry707062 (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Selegiline (oral)
File:Selegiline-2D-skeletal-alternative-view.png
Clinical data
Pregnancy
category
ATC code
Pharmacokinetic data
Bioavailability4.4%
Protein binding> 99.5%
Metabolismliver
Elimination half-life2 hours
Identifiers
CAS Number
PubChem CID
  • [https://pubchem.ncbi.nlm.nih.gov/compound/26757 26757
DrugBank
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC13H17N
Molar mass187.281 g/mol

Template:WikiDoc Sources

  1. Amsterdam, J. D. (2003-02). "A double-blind, placebo-controlled trial of the safety and efficacy of selegiline transdermal system without dietary restrictions in patients with major depressive disorder". Journal of Clinical Psychiatry. 64 (2): 208–214. Check date values in: |date= (help)
  2. http://www.fda.gov/bbs/topics/NEWS/2006/NEW01326.html
  3. Katzung, Bertram G. Basic & Clinical Pharmacology. 9th Edition. 2004. page 453. Lange Medical Books - McGraw Hill Publishers.
  4. Engberg G, Elebring T, Nissbrandt H (1991). "Deprenyl (selegiline), a selective MAO-B inhibitor with active metabolites; effects on locomotor activity, dopaminergic neurotransmission and firing rate of nigral dopamine neurons". J. Pharmacol. Exp. Ther. 259 (2): 841–7. PMID 1658311.